Update of pathophysiology and management of diabetic kidney disease

Journal of the Formosan Medical Association = Taiwan Yi Zhi
Yi-Chih LinTzong-Shinn Chu

Abstract

Diabetic kidney disease (DKD) is a major cause of morbidity and mortality in patients with diabetes mellitus and the leading cause of end-stage renal disease in the world. The most characteristic marker of DKD is albuminuria, which is associated with renal disease progression and cardiovascular events. Renal hemodynamics changes, oxidative stress, inflammation, hypoxia and overactive renin-angiotensin-aldosterone system (RAAS) are involved in the pathogenesis of DKD, and renal fibrosis plays the key role. Intensified multifactorial interventions, including RAAS blockades, blood pressure and glucose control, and quitting smoking, help to prevent DKD development and progression. In recent years, novel agents are applied for preventing DKD development and progression, including new types of glucose-lowering agents, pentoxifylline, vitamin D analog paricalcitol, pyridoxamine, ruboxistaurin, soludexide, Janus kinase inhibitors and nonsteroidal minerocorticoid receptor antagonists. In this review, recent large studies about DKD are also summarized.

Citations

Oct 15, 2018·Journal of Cellular Physiology·Yan-Zhe WangXiao-Xia Wang
Dec 6, 2018·The Journal of Physiology·Hong ChenKun Huang
Oct 28, 2018·Journal of Cellular Physiology·Habib YaribeygiAmirhossein Sahebkar
May 3, 2019·Immunological Investigations·Monika BuraczynskaWojciech Zaluska
Nov 14, 2019·Scientific Reports·Pascal Zhongping WeiCheuk Chun Szeto
Apr 9, 2020·Diabetes, Obesity & Metabolism·Jonatan Barrera-Chimal, Frédéric Jaisser
Aug 4, 2020·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Sihong ShenWeining Hu
Oct 3, 2020·Expert Opinion on Drug Discovery·Chhanda Charan DantaShang-Zhong Xu
May 3, 2019·The Korean Journal of Internal Medicine·Jun Young LeeJae Seok Kim
Jul 19, 2020·Cardiovascular Drugs and Therapy·Pappitha RajaDerek P Brazil
Jul 28, 2020·Biological Trace Element Research·Mohammad Mehdi OmmatiReza Heidari
Jul 27, 2020·Endocrinology, Diabetes & Metabolism·Oliver SchnellAntonio Ceriello
Nov 16, 2018·Journal of Nephrology·Paulo Giovanni de Albuquerque SuassunaMing-Chang Hu
Jul 14, 2020·Journal of Diabetes Research·Jiarong LvShizhong Bu
Sep 29, 2020·Frontiers in Endocrinology·Mina WangPeng Wei
Aug 11, 2020·Oxidative Medicine and Cellular Longevity·Jing GuoWei Jing Liu
Aug 9, 2020·BioMed Research International·Min LeiJia Guo
Jul 15, 2020·International Urology and Nephrology·Nutsiwat DidasNutjaree Jeenduang
Jan 27, 2019·Laboratory Investigation; a Journal of Technical Methods and Pathology·Zhiwen LiuLiyu He
Aug 9, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Hai-Jian SunJin-Song Bian
Jul 15, 2020·International Urology and Nephrology·Elias A T KochNakhoul Nakhoul
Sep 22, 2020·American Journal of Physiology. Renal Physiology·Kristan H ClevelandRick G Schnellmann
Aug 1, 2020·International Journal of Endocrinology·Yajing HuangYangang Wang
Mar 21, 2020·Frontiers in Pharmacology·Tamil Selvi LoganathanNoraidatulakma Abdullah
Oct 8, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Ajitesh RoyUNKNOWN Working Group of the Endocrine Society of Bengal
Nov 27, 2020·Clinical Journal of the American Society of Nephrology : CJASN·Sadayoshi ItoTomoko Sawanobori
Nov 23, 2020·Gene·Xiaoling Weng, Xiao-Jie Lu
Sep 22, 2020·Molecular Therapy : the Journal of the American Society of Gene Therapy·Patrick Ming-Kuen TangHui-Yao Lan
Nov 24, 2020·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Gyu S ChoiDae R Cha
Feb 2, 2021·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Heng-Cheng LuLi-Yu He
Feb 13, 2021·Frontiers in Pharmacology·Yue-Yu GuHui-Yao Lan
Dec 29, 2020·Frontiers in Pharmacology·Hiroko SakumaYusuke Suzuki
Feb 10, 2021·Journal of Diabetes and Its Complications·Masashi IshizuMunehide Matsuhisa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Related Papers

Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia
Mohamed E ElrggalMeguid El Nahas
World Journal of Diabetes
Montserrat B Duran-Salgado, Alberto F Rubio-Guerra
© 2022 Meta ULC. All rights reserved